By CDEP Media
Recently, concerns have been raised about the quality of medicines that are being sold in the Indian market, as the Central Drugs Standard Control Organisation (CDSCO), an apex body responsible for approval of new drugs and clinical trials identified over 50 drugs that failed to meet quality standards. This issue underscores the broader challenge of maintaining stringent quality controls in the pharmaceutical supply chain, not only for finished products but also for critical raw materials like isopropyl alcohol (IPA).
Article authored by Dr. Jaijit Bhattacharya and Vrinda Khanna
Copyright © 2024. Centre For Digital Economy Policy Research